FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969839426> ?p ?o ?g. }

• W1969839426 endingPage "75" @default.
• W1969839426 startingPage "64" @default.
• W1969839426 abstract "The majority of patients with acute myelogenous leukaemia (AML) and myelodysplastic syndromes (MDS) relapse, especially those with unfavourable cytogenetics. This study was designed to investigate the presence and frequency of minimal residual disease (MRD) in patients with AML or MDS ( n = 35) and numerical abnormalities of chromosomes 6, 7, 8, 9, 10, 17 and 18 in clinical remission by using a combination of fluorescence activated cell sorting (FACS), fluorescence in‐situ hybridization (FISH) and labelling with bromodeoxyuridine (BUdR). The technique enables the detection of as few as three leukaemic cells in 10 5 normal cells. MRD was detected in 33/35 patients in complete remission (CR). 16 patients relapsed (8/11 with monosomy 7, 4/17 with trisomy 8, and 4/7 with other cytogenetic abnormalities) after a median of 4.8 months (range 3–13). Levels of MRD ( P = 0.007) and proliferation index ( P = 0.011) were significantly higher in patients with monosomy 7 than in patients with trisomy 8 or other cytogenetic abnormalities. The percentage of cells in S‐phase, the number of abnormal cells and cytogenetic class were related to time to relapse ( P = 0.001) with S‐phase being the single most important prognostic factor ( P = 0.0001). We conclude that the combination of FACS/FISH/BUdR, which determines the number, phenotype and proliferation rate of very rare leukaemic cells in patients with AML or MDS in clinical remission, provides information that is useful in the identification of patients with high and low likelihood of relapse." @default.
• W1969839426 created "2016-06-24" @default.
• W1969839426 creator A5004888325 @default.
• W1969839426 creator A5024514967 @default.
• W1969839426 creator A5047514255 @default.
• W1969839426 creator A5062637952 @default.
• W1969839426 creator A5068481754 @default.
• W1969839426 creator A5071222148 @default.
• W1969839426 creator A5081477605 @default.
• W1969839426 creator A5088414474 @default.
• W1969839426 date "1997-10-01" @default.
• W1969839426 modified "2023-10-16" @default.
• W1969839426 title "Minimal residual disease in acute myelogenous leukaemia and myelodysplastic syndromes: a follow‐up of patients in clinical remission" @default.
• W1969839426 cites W1540355515 @default.
• W1969839426 cites W1602123006 @default.
• W1969839426 cites W1981696481 @default.
• W1969839426 cites W2037921517 @default.
• W1969839426 cites W2040836990 @default.
• W1969839426 cites W2040998461 @default.
• W1969839426 cites W2069644796 @default.
• W1969839426 cites W2083600033 @default.
• W1969839426 cites W2134362985 @default.
• W1969839426 cites W21433988 @default.
• W1969839426 cites W2146174795 @default.
• W1969839426 cites W2149528811 @default.
• W1969839426 cites W215965135 @default.
• W1969839426 cites W2201630912 @default.
• W1969839426 cites W2313057740 @default.
• W1969839426 cites W2339313676 @default.
• W1969839426 cites W2343863476 @default.
• W1969839426 cites W2401640396 @default.
• W1969839426 cites W2405562562 @default.
• W1969839426 cites W2409799523 @default.
• W1969839426 cites W2412696314 @default.
• W1969839426 cites W2415963854 @default.
• W1969839426 cites W2426539048 @default.
• W1969839426 cites W2463212465 @default.
• W1969839426 cites W2508890996 @default.
• W1969839426 cites W2414907141 @default.
• W1969839426 doi "https://doi.org/10.1046/j.1365-2141.1997.3323151.x" @default.
• W1969839426 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9359505" @default.
• W1969839426 hasPublicationYear "1997" @default.
• W1969839426 type Work @default.
• W1969839426 sameAs 1969839426 @default.
• W1969839426 citedByCount "26" @default.
• W1969839426 countsByYear W19698394262013 @default.
• W1969839426 countsByYear W19698394262014 @default.
• W1969839426 countsByYear W19698394262020 @default.
• W1969839426 crossrefType "journal-article" @default.
• W1969839426 hasAuthorship W1969839426A5004888325 @default.
• W1969839426 hasAuthorship W1969839426A5024514967 @default.
• W1969839426 hasAuthorship W1969839426A5047514255 @default.
• W1969839426 hasAuthorship W1969839426A5062637952 @default.
• W1969839426 hasAuthorship W1969839426A5068481754 @default.
• W1969839426 hasAuthorship W1969839426A5071222148 @default.
• W1969839426 hasAuthorship W1969839426A5081477605 @default.
• W1969839426 hasAuthorship W1969839426A5088414474 @default.
• W1969839426 hasBestOaLocation W19698394261 @default.
• W1969839426 hasConcept C104317684 @default.
• W1969839426 hasConcept C126322002 @default.
• W1969839426 hasConcept C142724271 @default.
• W1969839426 hasConcept C143998085 @default.
• W1969839426 hasConcept C174475383 @default.
• W1969839426 hasConcept C2776229224 @default.
• W1969839426 hasConcept C2777542201 @default.
• W1969839426 hasConcept C2779142324 @default.
• W1969839426 hasConcept C2779823535 @default.
• W1969839426 hasConcept C2780007613 @default.
• W1969839426 hasConcept C2780365373 @default.
• W1969839426 hasConcept C2780817109 @default.
• W1969839426 hasConcept C30481170 @default.
• W1969839426 hasConcept C53226629 @default.
• W1969839426 hasConcept C54355233 @default.
• W1969839426 hasConcept C71924100 @default.
• W1969839426 hasConcept C86803240 @default.
• W1969839426 hasConcept C90924648 @default.
• W1969839426 hasConceptScore W1969839426C104317684 @default.
• W1969839426 hasConceptScore W1969839426C126322002 @default.
• W1969839426 hasConceptScore W1969839426C142724271 @default.
• W1969839426 hasConceptScore W1969839426C143998085 @default.
• W1969839426 hasConceptScore W1969839426C174475383 @default.
• W1969839426 hasConceptScore W1969839426C2776229224 @default.
• W1969839426 hasConceptScore W1969839426C2777542201 @default.
• W1969839426 hasConceptScore W1969839426C2779142324 @default.
• W1969839426 hasConceptScore W1969839426C2779823535 @default.
• W1969839426 hasConceptScore W1969839426C2780007613 @default.
• W1969839426 hasConceptScore W1969839426C2780365373 @default.
• W1969839426 hasConceptScore W1969839426C2780817109 @default.
• W1969839426 hasConceptScore W1969839426C30481170 @default.
• W1969839426 hasConceptScore W1969839426C53226629 @default.
• W1969839426 hasConceptScore W1969839426C54355233 @default.
• W1969839426 hasConceptScore W1969839426C71924100 @default.
• W1969839426 hasConceptScore W1969839426C86803240 @default.
• W1969839426 hasConceptScore W1969839426C90924648 @default.
• W1969839426 hasIssue "1" @default.
• W1969839426 hasLocation W19698394261 @default.
• W1969839426 hasLocation W19698394262 @default.
• W1969839426 hasOpenAccess W1969839426 @default.

• next